Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis

Estrogens have neuroprotective actions depending on estrogen type, dose, and timing in both preclinical models and in women during health and disease. Serum neurofilament light chain is a putative biomarker of neurodegeneration in multiple sclerosis, aging, and other neurodegenerative diseases. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Voskuhl, Rhonda, Kuhle, Jens, Siddarth, Prabha, Itoh, Noriko, Patel, Kevin, MacKenzie‐Graham, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380170/
https://www.ncbi.nlm.nih.gov/pubmed/35770318
http://dx.doi.org/10.1002/acn3.51622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380170/
https://www.ncbi.nlm.nih.gov/pubmed/35770318
http://dx.doi.org/10.1002/acn3.51622

Ejemplares similares